Roche MS drug Ocrevus approved by FDA after 3-month delay - Nasdaq

Nasdaq

Roche MS drug Ocrevus approved by FDA after 3-month delay Nasdaq March 28 (Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's <ROG.S> multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing ... and more »

from Health - Google News http://ift.tt/2nKiZly